Publications

Found 2 results
Filters: Author is T.J. Chow  [Clear All Filters]
2012
H. C. Loh, Tang, P. Y., Tee, S. F., Chow, T. J., Cheah, Y. C., and Singh, S. S. J., BDNF and DARPP-32 genes are not risk factors for schizophrenia in the Malay population, vol. 11, pp. 725-730, 2012.
Albert KA, Hemmings HC Jr, Adamo AI, Potkin SG, et al. (2002). Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch. Gen. Psychiatry 59: 705-712. http://dx.doi.org/10.1001/archpsyc.59.8.705 PMid:12150646 Angelucci F, Brene S and Mathe AA (2005). BDNF in schizophrenia, depression and corresponding animal models. Mol. Psychiatry 10: 345-352. http://dx.doi.org/10.1038/sj.mp.4001637 PMid:15655562 Chen ZY, Jing D, Bath KG, Ieraci A, et al. (2006). Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314: 140-143. http://dx.doi.org/10.1126/science.1129663 PMid:17023662    PMCid:1880880 Egan MF, Weinberger DR and Lu B (2003). Schizophrenia, III: brain-derived neurotropic factor and genetic risk. Am. J. Psychiatry 160: 1242. http://dx.doi.org/10.1176/appi.ajp.160.7.1242 PMid:12832235 Fienberg AA, Hiroi N, Mermelstein PG, Song W, et al. (1998). DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281: 838-842. http://dx.doi.org/10.1126/science.281.5378.838 PMid:9694658 Gratacòs M, González JR, Mercader JM, de Cid R, et al. (2007). Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol. Psychiatry 61: 911-922. http://dx.doi.org/10.1016/j.biopsych.2006.08.025 PMid:17217930 Hong CJ, Yu YW, Lin CH and Tsai SJ (2003). An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci. Lett. 349: 206-208. http://dx.doi.org/10.1016/S0304-3940(03)00828-0 Jonsson EG, Edman-Ahlbom B, Sillen A, Gunnar A, et al. (2006). Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog. Neuropsychopharmacol. Biol. Psychiatry 30: 924-933. http://dx.doi.org/10.1016/j.pnpbp.2006.02.008 PMid:16581172 Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, et al. (2007). Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatry Genet. 17: 165-170. http://dx.doi.org/10.1097/YPG.0b013e32801da2e2 PMid:17417060 Li CH, Liao HM, Hung TW and Chen CH (2006). Mutation analysis of DARPP-32 as a candidate gene for schizophrenia. Schizophr. Res. 87: 1-5. http://dx.doi.org/10.1016/j.schres.2006.04.003 PMid:16750903 Meyer-Lindenberg A, Straub RE, Lipska BK, Verchinski BA, et al. (2007). Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J. Clin. Invest. 117: 672-682. http://dx.doi.org/10.1172/JCI30413 PMid:17290303    PMCid:1784004 Muglia P, Vicente AM, Verga M, King N, et al. (2003). Association between the BDNF gene and schizophrenia. Mol. Psychiatry 8: 146-147. http://dx.doi.org/10.1038/sj.mp.4001221 PMid:12610646 Murray RM, Sham P, van Os J, Zanelli J, et al. (2004). A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr. Res. 71: 405-416. http://dx.doi.org/10.1016/j.schres.2004.03.002 PMid:15474912 Nanko S, Kunugi H, Hirasawa H, Kato N, et al. (2003). Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis. Schizophr. Res. 62: 281-283. http://dx.doi.org/10.1016/S0920-9964(02)00349-3 Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, et al. (2005). BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry 10: 208-212. http://dx.doi.org/10.1038/sj.mp.4001575 PMid:15630410 Nishi A, Watanabe Y, Higashi H, Tanaka M, et al. (2005). Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades. Proc. Natl. Acad. Sci. U. S. A. 102: 1199-1204. http://dx.doi.org/10.1073/pnas.0409138102 PMid:15657149    PMCid:545831 Qian L, Zhao J, Shi Y, Zhao X, et al. (2007). Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis. Biochem. Biophys. Res. Commun. 353: 738-743. http://dx.doi.org/10.1016/j.bbrc.2006.12.121 PMid:17196936 Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59 (Suppl 20): 22-33. Skibinska M, Hauser J, Czerski PM, Leszczynska-Rodziewicz A, et al. (2004). Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. World J. Biol. Psychiatry 5: 215-220. http://dx.doi.org/10.1080/15622970410029936 PMid:15543516 Squassina A, Piccardi P, Del Zompo M, Rossi A, et al. (2010). NRG1 and BDNF genes in schizophrenia: an association study in an Italian case-control sample. Psychiatry Res. 176: 82-84. http://dx.doi.org/10.1016/j.psychres.2009.03.017 PMid:20061032 Svenningsson P, Tzavara ET, Liu F, Fienberg AA, et al. (2002a). DARPP-32 mediates serotonergic neurotransmission in the forebrain. Proc. Natl. Acad. Sci. U. S. A. 99: 3188-3193. http://dx.doi.org/10.1073/pnas.052712699 PMid:11880652    PMCid:122494 Svenningsson P, Tzavara ET, Witkin JM, Fienberg AA, et al. (2002b). Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proc. Natl. Acad. Sci. U. S. A. 99: 3182-3187. http://dx.doi.org/10.1073/pnas.052712799 PMid:11880651    PMCid:122493 Takahashi T, Suzuki M, Tsunoda M, Kawamura Y, et al. (2007). Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons. Neurosci. Lett. 435: 34-39. http://dx.doi.org/10.1016/j.neulet.2008.02.004 PMid:18325670 Tee SF, Chow TJ, Tang PY and Loh HC (2010). Linkage of schizophrenia with TPH2 and 5-HTR2A gene polymorphisms in the Malay population. Genet. Mol. Res. 9: 1274-1278. http://dx.doi.org/10.4238/vol9-3gmr789 PMid:20623453 Tee SF, Tang PY and Loh HC (2011). No evidence for association between DRD3 and COMT with schizophrenia in a Malay population. Genet. Mol. Res. 10: 1850-1855. http://dx.doi.org/10.4238/vol10-3gmr1237 PMid:21948748 Tee SF, Tang PY and Loh HC (2012). COMT haplotype analyses in Malaysian with schizophrenia. Psychiatry Res. 195: 83-84. http://dx.doi.org/10.1016/j.psychres.2011.07.039 PMid:21872942 Xu MQ, St Clair D, Ott J, Feng GY, et al. (2007). Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophr. Res. 91: 6-13. http://dx.doi.org/10.1016/j.schres.2006.12.008 PMid:17289348
2010
S. F. Tee, Chow, T. J., Tang, P. Y., and Loh, H. C., Linkage of schizophrenia with TPH2 and 5-HTR2A gene polymorphisms in the Malay population, vol. 9, pp. 1274-1278, 2010.
Abdolmaleky HM, Faraone SV, Glatt SJ and Tsuang MT (2004). Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr. Res. 67: 53-62. http://dx.doi.org/10.1016/S0920-9964(03)00183-X   Andaya BW and Andaya LY (1982). A History of Malaysia. Macmillan, London.   Anonymous (2003-2005). National Mental Health Registry Report. Department of Psychiatric and Mental Health, Hospital Kuala Lumpur: National Mental Health Registry, Kuala Lumpur.   Anttila S, Viikki M, Huuhka K, Huuhka M, et al. (2009). TPH2 polymorphisms may modify clinical picture in treatment-resistant depression. Neurosci. Lett. 464: 43-46. http://dx.doi.org/10.1016/j.neulet.2009.08.018 PMid:19679166   Arango V, Underwood MD and Mann JJ (1997). Postmortem findings in suicide victims. Implications for in vivo imaging studies. Ann. N. Y. Acad. Sci. 836: 269-287. http://dx.doi.org/10.1111/j.1749-6632.1997.tb52365.x PMid:9616804   Chen K, Yang W, Grimsby J and Shih JC (1992). The human 5-HT2 receptor is encoded by a multiple intron-exon gene. Brain Res. Mol. Brain Res. 14: 20-26. http://dx.doi.org/10.1016/0169-328X(92)90005-V   Fitzpatrick PF (1999). Tetrahydropterin-dependent amino acid hydroxylases. Annu. Rev. Biochem. 68: 355-381. http://dx.doi.org/10.1146/annurev.biochem.68.1.355 PMid:10872454   Li K, Zhang YQ, Yu P and Cheng YR (2006). Effect of SNP at position 40237 in exon 7 of the TPH2 gene on susceptibility to suicide. Brain Res. 1122: 24-26. http://dx.doi.org/10.1016/j.brainres.2006.09.007 PMid:17011525   Mann JJ, Currier D, Murphy L, Huang YY, et al. (2008). No association between a TPH2 promoter polymorphism and mood disorders or monoamine turnover. J. Affect. Disord. 106: 117-121. http://dx.doi.org/10.1016/j.jad.2007.05.031 PMid:17604842 PMCid:2756663   Maron E, Toru I, Must A, Tasa G, et al. (2007). Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder. Neurosci. Lett. 411: 180-184. http://dx.doi.org/10.1016/j.neulet.2006.09.060 PMid:17123728   Nagaraj S, Lee KH, Tey NP, Ng CW, et al. (2008). Counting and Integration: The Experience of Malaysia, Working Paper Series, No. 2008-3. Faculty of Economics and Administration, University of Malaya, Kuala Lumpur.   Nielsen DA, Virkkunen M, Lappalainen J, Eggert M, et al. (1998). A tryptophan hydroxylase gene marker for suicidality and alcoholism. Arch. Gen. Psychiatry 55: 593-602. http://dx.doi.org/10.1001/archpsyc.55.7.593 PMid:9672049   Pe-as-Lledó EM, Dorado P, Caceres MC, de la Rubia A, et al. (2007). Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs. Clin. Chem. Lab. Med. 45: 835-838. PMid:17617023   Prasad KM, Talkowski ME, Chowdari KV, McClain L, et al. (2009). Candidate genes and their interactions with other genetic/environmental risk factors in the etiology of schizophrenia. Brain Res. Bull. (in press). PMid:19729054   Riedel WJ, Sobczak S and Schmitt JA (2003). Tryptophan modulation and cognition. Adv. Exp. Med. Biol. 527: 207-213. http://dx.doi.org/10.1007/978-1-4615-0135-0_24 PMid:15206734   Sáiz PA, Garcia-Portilla MP, Arango C, Morales B, et al. (2007). Association study of serotonin 2A receptor (5-HT2A) and serotonin transporter (5-HTT) gene polymorphisms with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 31: 741-745. http://dx.doi.org/10.1016/j.pnpbp.2007.01.012 PMid:17291660   Schulze TG and McMahon FJ (2002). Genetic association mapping at the crossroads: which test and why? Overview and practical guidelines. Am. J. Med. Genet. 114: 1-11. http://dx.doi.org/10.1002/ajmg.10042 PMid:11840498   Schwab SG and Wildenauer DB (2008). Research on causes for schizophrenia: are we close? Schizophr. Res. 102: 29-30. http://dx.doi.org/10.1016/j.schres.2008.04.005 PMid:18705138   Semwal P, Prasad S, Varma PG, Bhagwat AM, et al. (2002). Candidate gene polymorphisms among North Indians and their association with schizophrenia in a case-control study. J. Genet. 81: 65-71. http://dx.doi.org/10.1007/BF02715902 PMid:12532038   Sparkes RS, Lan N, Klisak I, Mohandas T, et al. (1991). Assignment of a serotonin 5HT-2 receptor gene (HTR2) to human chromosome 13q14-q21 and mouse chromosome 14. Genomics 9: 461-465. http://dx.doi.org/10.1016/0888-7543(91)90411-7   Virgos C, Martorell L, Valero J, Figuera L, et al. (2001). Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr. Res. 49: 65-71. http://dx.doi.org/10.1016/S0920-9964(00)00106-7   Zill P, Buttner A, Eisenmenger W, Moller HJ, et al. (2004a). Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol. Psychiatry 56: 581-586. http://dx.doi.org/10.1016/j.biopsych.2004.07.015 PMid:15476687   Zill P, Baghai TC, Zwanzger P, Schule C, et al. (2004b). SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol. Psychiatry 9: 1030-1036. http://dx.doi.org/10.1038/sj.mp.4001525 PMid:15124006   Zill P, Buttner A, Eisenmenger W, Moller HJ, et al. (2007). Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study. J. Psychiatr. Res. 41: 168-173. http://dx.doi.org/10.1016/j.jpsychires.2005.05.004 PMid:16023677